Veritti, Daniele http://orcid.org/0000-0003-0148-5348
Rubinato, Leopoldo
Sarao, Valentina
De Nardin, Axel
Foresti, Gian Luca
Lanzetta, Paolo
Funding for this research was provided by:
Università degli Studi di Udine
Article History
Received: 19 January 2023
Revised: 24 July 2023
Accepted: 15 September 2023
First Online: 25 September 2023
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: Daniele Veritti, Leopoldo Rubinato, Valentina Sarao, Axel De Nardin, and Gianluca Foresti declare they have no financial interests. Paolo Lanzetta is a consultant to Aerie, Apellis, Bayer, Biogen, Centervue, Novartis, and Roche.